1. Yagoda A, Abi-Rached B, Petrylak D. Chemotherapy for advanced renal cell carcinoma: 1983–1993. Semin Oncol 1995;22:42–60.
2. Motzer RJ, Vogelzang NJ. Chemotherapy for renal cell carcinoma. In: Raghaven D, Scher HI, Leibel SA, et al., eds. Principles and Practice of Genitourinary Oncology. Philadelphia: Lippincott-Raven, 1997:885–896.
3. Voglezang NJ, Priest ER, Borden L. Spontaneous regression of histologically proved pulmonary metastases from renal cell carcinoma: a case with 5-year follow-up. J Urol 1992;148:1247–1248.
4. Finke JH, Rayman P, Hart L, et al. Characterization of TIL subsets from human renal carcinoma: specific reactivity defined by cytotoxicity, IFN-γ secretion, and proliferation. J Immunother 1994;15:91–104.
5. Oliver RTD, Mehta A, Barnett MJ. A phase 2 study of surveillance in patients with metastatic renal cell carcinoma and assessment of response of such patients to therapy on progression. Mol Biother 1998;1:14–20.